Evidence map›Paper›PMID 36795755›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone.

Patrick Hanna, Ashok Khatri, Shawn Choi, Severine Brabant, Matti L Gild, Marie L Piketty, Bruno Francou, Dominique Prié, John T Potts, Roderick J Clifton-Bligh and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Imprinting and skeletal disorders: lessons from pseudohypoparathyroidism and related disorders.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Patrick HannaEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Ashok KhatriEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Shawn ChoiEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Severine BrabantUniversité Paris Cité, Institut Necker Enfants Malades, Institut National de la Santé et de la Recherche Médicale U1151, Service des Explorations Fonctionnelles, Hôpital Necker Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris 75015, France.ORCID 0000-0002-7590-3963
Matti L GildDepartment of Endocrinology Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Marie L PikettyUniversité Paris Cité, Institut Necker Enfants Malades, Institut National de la Santé et de la Recherche Médicale U1151, Service des Explorations Fonctionnelles, Hôpital Necker Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris 75015, France.
Bruno FrancouUniversité Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, Physiologie et Physiopathologie Endocrinienne, Assistance Publique - Hôpitaux de Paris, Department of Molecular Genetics, Bicêtre Paris-Saclay Hospital, Le Kremlin Bicêtre 94270, France.ORCID 0000-0002-3903-2320
Dominique PriéUniversité Paris Cité, Institut Necker Enfants Malades, Institut National de la Santé et de la Recherche Médicale U1151, Service des Explorations Fonctionnelles, Hôpital Necker Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris 75015, France.
John T PottsEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.ORCID 0000-0003-3772-3432
Roderick J Clifton-BlighDepartment of Endocrinology Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Agnès LinglartAssistance Publique - Hôpitaux de Paris, Endocrinology and Diabetology for Children, Bicêtre Paris Saclay Hospital, Le Kremlin Bicêtre 94270, France.ORCID 0000-0003-3455-002X
Thomas J GardellaEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Harald JüppnerEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Harvard University · USHôpital Necker-Enfants Malades · FRInserm · FRThe University of Sydney · AU

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1986 to 2023
$44.4M
PTH/PTHRP RECEPTOR DEFECTS IN PSEUDOHYPOPARATHYROIDISMR01DK046718 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1993 to 2024
$6.0M
Molecular Definition of PseudohypoparathyroidismR37DK046718 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 2002 to 2011
$4.0M
Molecular Definition of PseudohypoparathyroidismR56DK046718 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 2012 to 2012
$218k
NIDDK NIH HHS P01 DK011794NIDDK NIH HHS R01 DK046718NIDDK NIH HHS R37 DK046718NIDDK NIH HHS R56 DK046718
6 · The paper itself

Abstract

Like other secreted peptides, nascent parathyroid hormone (PTH) is synthesized with a pre- and a pro-sequence (25 and 6 amino acids, respectively). These precursor segments are sequentially removed in parathyroid cells before packaging into secretory granules. Three patients from two unrelated families who presented during infancy with symptomatic hypocalcemia were found to have a homozygous serine (S) to proline (P) change affecting the first amino acid of the mature PTH. Unexpectedly, biological activity of synthetic [P1]PTH(1-34) was indistinguishable from that of unmodified [S1]PTH(1-34). However, in contrast to conditioned medium from COS-7 cells expressing prepro[S1]PTH(1-84), medium from cells expressing prepro[P1]PTH(1-84) failed to stimulate cAMP production despite similar PTH levels when measured by an intact assay that detects PTH(1-84) and large amino-terminally truncated fragments thereof. Analysis of the secreted, but inactive PTH variant led to the identification of pro[P1]PTH(-6 to +84). Synthetic pro[P1]PTH(-6 to +34) and pro[S1]PTH(-6 to +34) had much less bioactivity than the corresponding PTH(1-34) analogs. Unlike pro[S1]PTH(-6 to +34), pro[P1]PTH(-6 to +34) was resistant to cleavage by furin suggesting that the amino acid variant impairs preproPTH processing. Consistent with this conclusion, plasma of patients with the homozygous P1 mutation had elevated proPTH levels, as determined with an in-house assay specific for pro[P1]PTH(-6 to +84). In fact, a large fraction of PTH detected by the commercial intact assay represented the secreted pro[P1]PTH. In contrast, two commercial biointact assays that use antibodies directed against the first few amino acid residues of PTH(1-84) for capture or detection failed to detect pro[P1]PTH.

Indexed as

HypocalcemiaAmino AcidsHumansMutationParathyroid HormoneProlineAmino AcidsParathyroid HormoneProlinecalciumhypoparathyroidismphosphatepseudohypoparathyroidismPTH

Identifiers

PMID36795755
PMCPMC9974466
OpenAlexW4321003934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.